This title appears in the Scientific Report :
2011
Please use the identifier:
http://dx.doi.org/10.2967/jnumed.111.091801 in citations.
Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord
Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord
MRI offers perfect visualization of spondylotic stenosis of the cervical spine, but morphologic imaging does not correlate with clinical symptoms and postoperative recovery after decompression surgery. In this prospective study, we investigated the role of (18)F-FDG PET in patients with degenerative...
Saved in:
Personal Name(s): | Floeth, F.W. |
---|---|
Stoffels, G. / Herdmann, J. / Eicker, S. / Galldiks, N. / Steiger, H.-J. / Langen, K.-J. | |
Contributing Institute: |
Kognitive Neurowissenschaften; INM-3 Physik der Medizinischen Bildgebung; INM-4 |
Published in: | Journal of Nuclear Medicine Journal of nuclear medicine, 52 52 (2011 2011) 9 9, S. 1385-1391 1385-1391 |
Imprint: |
New York, NY
Society of Nuclear Medicine
2011
2011-08-18 2011-09-01 2011-09-01 |
Physical Description: |
1385 - 1391 |
PubMed ID: |
21852356 |
DOI: |
10.2967/jnumed.111.091801 |
Document Type: |
Journal Article |
Research Program: |
(Dys-)function and Plasticity Funktion und Dysfunktion des Nervensystems |
Series Title: |
Journal of Nuclear Medicine
52 |
Subject (ZB): | |
Publikationsportal JuSER |
LEADER | 07479nam a2201153 a 4500 | ||
---|---|---|---|
001 | 16700 | ||
005 | 20210129210647.0 | ||
024 | 7 | |2 pmid |a pmid:21852356 | |
024 | 7 | |2 DOI |a 10.2967/jnumed.111.091801 | |
024 | 7 | |2 WOS |a WOS:000294480900032 | |
024 | 7 | |a altmetric:241398 |2 altmetric | |
037 | |a PreJuSER-16700 | ||
041 | |a eng | ||
082 | |a 610 | ||
084 | |2 WoS |a Radiology, Nuclear Medicine & Medical Imaging | ||
100 | 1 | |a Floeth, F.W. |b 0 |0 P:(DE-HGF)0 | |
245 | |a Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord | ||
260 | |a New York, NY |b Society of Nuclear Medicine |c 2011 | ||
264 | 1 | |3 online |2 Crossref |b Society of Nuclear Medicine |c 2011-08-18 | |
264 | 1 | |3 print |2 Crossref |b Society of Nuclear Medicine |c 2011-09-01 | |
264 | 1 | |3 print |2 Crossref |b Society of Nuclear Medicine |c 2011-09-01 | |
300 | |a 1385 - 1391 | ||
440 | 0 | |a Journal of Nuclear Medicine |x 0097-9058 |0 3621 |y 9 |v 52 | |
500 | |a Record converted from VDB: 12.11.2012 | ||
520 | |a MRI offers perfect visualization of spondylotic stenosis of the cervical spine, but morphologic imaging does not correlate with clinical symptoms and postoperative recovery after decompression surgery. In this prospective study, we investigated the role of (18)F-FDG PET in patients with degenerative stenosis of the cervical spinal cord in relation to postsurgical outcome.Twenty patients with monosegmental spondylotic stenosis of the middle cervical spine (C3/C4 or C4/C5) showing intramedullary hyperintensity on T2-weighted MRI and clinical symptoms of myelopathy (myelopathic patients) were investigated by (18)F-FDG PET. Maximum standardized uptake values (SUV(max)) were measured at all levels of the cervical spine (C1-C7). Decompression surgery and anterior cervical fusion were performed on all patients, and clinical status (Japanese Orthopedic Association [JOA] score) was assessed before and 6 mo after surgery. The (18)F-FDG data of 10 individuals without cervical spine pathology were used as a reference (controls).The myelopathic patients showed a significant decrease in (18)F-FDG uptake in the area of the lower cervical cord, compared with the control group (C7 SUV(max), 1.49 ± 0.18 vs. 1.71 ± 0.27, P = 0.01). Ten myelopathic patients exhibited focally increased (18)F-FDG uptake at the level of the stenosis (SUV(max), 2.27 ± 0.41 vs. 1.75 ± 0.22, P = 0.002). The remaining 10 patients showed inconspicuous (18)F-FDG uptake at the area of the stenosis. Postoperatively, the patients with focally increased (18)F-FDG accumulation at the level of stenosis showed good clinical recovery and a significant improvement in JOA scores (13.6 ± 2.3 vs. 9.5 ± 2.5, P = 0.001), whereas no significant improvement was observed in the remaining patients (JOA score, 12.0 ± 2.4 vs. 11.6 ± 2.5, not statistically significant). Multiple regression analysis identified the presence of focally increased (18)F-FDG uptake at the level of the stenosis as an independent predictor of postoperative outcome (P = 0.002).The results suggest that regional changes in (18)F-FDG uptake have prognostic significance in compression-induced cervical myelopathy that may be helpful in decisions on the timing of surgery. | ||
588 | |a Dataset connected to Web of Science, Pubmed | ||
650 | 2 | |2 MeSH |a Aged | |
650 | 2 | |2 MeSH |a Aged, 80 and over | |
650 | 2 | |2 MeSH |a Cervical Vertebrae: radionuclide imaging | |
650 | 2 | |2 MeSH |a Cervical Vertebrae: surgery | |
650 | 2 | |2 MeSH |a Data Interpretation, Statistical | |
650 | 2 | |2 MeSH |a Female | |
650 | 2 | |2 MeSH |a Fluorodeoxyglucose F18: diagnostic use | |
650 | 2 | |2 MeSH |a Humans | |
650 | 2 | |2 MeSH |a Image Processing, Computer-Assisted | |
650 | 2 | |2 MeSH |a Magnetic Resonance Imaging | |
650 | 2 | |2 MeSH |a Male | |
650 | 2 | |2 MeSH |a Middle Aged | |
650 | 2 | |2 MeSH |a Nervous System Diseases: etiology | |
650 | 2 | |2 MeSH |a Orthopedic Procedures | |
650 | 2 | |2 MeSH |a Positron-Emission Tomography: methods | |
650 | 2 | |2 MeSH |a Prognosis | |
650 | 2 | |2 MeSH |a Radiopharmaceuticals: diagnostic use | |
650 | 2 | |2 MeSH |a Software | |
650 | 2 | |2 MeSH |a Spinal Cord Compression: radionuclide imaging | |
650 | 2 | |2 MeSH |a Spinal Cord Compression: surgery | |
650 | 2 | |2 MeSH |a Spinal Cord Diseases: radionuclide imaging | |
650 | 2 | |2 MeSH |a Spinal Cord Diseases: surgery | |
650 | 2 | |2 MeSH |a Spinal Stenosis: radionuclide imaging | |
650 | 2 | |2 MeSH |a Spinal Stenosis: surgery | |
650 | 2 | |2 MeSH |a Treatment Outcome | |
650 | 7 | |0 0 |2 NLM Chemicals |a Radiopharmaceuticals | |
650 | 7 | |0 63503-12-8 |2 NLM Chemicals |a Fluorodeoxyglucose F18 | |
650 | 7 | |a J |2 WoSType | |
653 | 2 | 0 | |2 Author |a positron emission tomography |
653 | 2 | 0 | |2 Author |a [F-18] fluorodeoxyglucose |
653 | 2 | 0 | |2 Author |a [F-18] FDG PET |
653 | 2 | 0 | |2 Author |a cervical myelopathy |
653 | 2 | 0 | |2 Author |a degenerative spinal stenosis |
653 | 2 | 0 | |2 Author |a spinal cord recovery |
700 | 1 | |a Stoffels, G. |b 1 |u FZJ |0 P:(DE-Juel1)131627 | |
700 | 1 | |a Herdmann, J. |b 2 |0 P:(DE-HGF)0 | |
700 | 1 | |a Eicker, S. |b 3 |0 P:(DE-HGF)0 | |
700 | 1 | |a Galldiks, N. |b 4 |u FZJ |0 P:(DE-Juel1)VDB73298 | |
700 | 1 | |a Steiger, H.-J. |b 5 |0 P:(DE-HGF)0 | |
700 | 1 | |a Langen, K.-J. |b 6 |u FZJ |0 P:(DE-Juel1)131777 | |
773 | 1 | 8 | |a 10.2967/jnumed.111.091801 |b : Society of Nuclear Medicine, 2011-08-18 |n 9 |p 1385-1391 |3 journal-article |2 Crossref |t Journal of Nuclear Medicine |v 52 |y 2011 |x 0161-5505 |
773 | |a 10.2967/jnumed.111.091801 |g Vol. 52, p. 1385 - 1391 |p 1385-1391 |n 9 |q 52<1385 - 1391 |0 PERI:(DE-600)2040222-3 |t Journal of nuclear medicine |v 52 |y 2011 |x 0161-5505 | ||
856 | 7 | |u http://dx.doi.org/10.2967/jnumed.111.091801 | |
909 | C | O | |o oai:juser.fz-juelich.de:16700 |p VDB |
913 | 2 | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |2 G:(DE-HGF)POF3-500 |v (Dys-)function and Plasticity |x 0 | |
913 | 1 | |a DE-HGF |0 G:(DE-HGF)POF2-89572 |v (Dys-)function and Plasticity |x 1 |4 G:(DE-HGF)POF |1 G:(DE-HGF)POF3-890 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-800 |b Programmungebundene Forschung |l ohne Programm | |
914 | 1 | |y 2011 | |
915 | |0 StatID:(DE-HGF)0010 |a JCR/ISI refereed | ||
970 | |a VDB:(DE-Juel1)130894 | ||
980 | |a VDB | ||
980 | |a ConvertedRecord | ||
980 | |a journal | ||
980 | |a I:(DE-Juel1)INM-3-20090406 | ||
980 | |a I:(DE-Juel1)INM-4-20090406 | ||
980 | |a UNRESTRICTED | ||
536 | |a (Dys-)function and Plasticity |0 G:(DE-HGF)POF2-89572 |c POF2-89572 |x 1 |f POF II T | ||
536 | |a Funktion und Dysfunktion des Nervensystems |0 G:(DE-Juel1)FUEK409 |2 G:(DE-HGF) |x 0 |c FUEK409 | ||
336 | |a ARTICLE |2 BibTeX | ||
336 | |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0) |0 0 |2 EndNote | ||
336 | |a Output Types/Journal article |2 DataCite | ||
336 | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) | ||
336 | |a article |2 DRIVER | ||
336 | |a JOURNAL_ARTICLE |2 ORCID | ||
981 | |a I:(DE-Juel1)INM-4-20090406 | ||
920 | |k Kognitive Neurowissenschaften; INM-3 |l Kognitive Neurowissenschaften |g INM |0 I:(DE-Juel1)INM-3-20090406 |x 0 | ||
920 | |k Physik der Medizinischen Bildgebung; INM-4 |l Physik der Medizinischen Bildgebung |g INM |0 I:(DE-Juel1)INM-4-20090406 |x 1 | ||
990 | |a Floeth, F.W. |b 0 |0 P:(DE-HGF)0 | ||
991 | |a Langen, Karl-Josef |b 6 |u FZJ |0 P:(DE-Juel1)131777 | ||
991 | |a Steiger, H.-J. |b 5 |0 P:(DE-HGF)0 | ||
991 | |a Galldiks, N. |b 4 |u FZJ |0 P:(DE-Juel1)VDB73298 | ||
991 | |a Eicker, S. |b 3 |0 P:(DE-HGF)0 | ||
991 | |a Herdmann, J. |b 2 |0 P:(DE-HGF)0 | ||
991 | |a Stoffels, Gabriele |b 1 |u FZJ |0 P:(DE-Juel1)131627 |